The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat

被引:52
作者
Abbott, CR [1 ]
Small, CJ [1 ]
Sajedi, A [1 ]
Smith, KL [1 ]
Parkinson, JRC [1 ]
Broadhead, LL [1 ]
Ghatei, MA [1 ]
Bloom, SR [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Endocrine Unit, London W12 0NN, England
基金
英国惠康基金;
关键词
PYY; GLP-1; oxyntomodulin; gastrointestinal hormones; food intake; stress;
D O I
10.1038/sj.ijo.0803137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Peptide YY3-36 (PYY3-36), glucagon-like peptide-1 (GLP-1), oxyntomodulin and cholecystokinin (CCK) are gastrointestinal-derived hormones that are released postprandially in proportion to the amount of calories ingested. All significantly reduce food intake following peripheral administration to rodents. We have investigated the effect of handling, exposure to a novel environment or to environmental enrichment on the anorectic effect of these gut hormones. Results: Results suggest that the transfer of a rat into a novel environment ( cage change) inhibits the anorectic response to peripherally administered PYY3-36 and oxyntomodulin (1 h food intake reduction (% saline control): PYY/ home cage 82.3 +/- 5.9%, P < 0.05; PYY/ clean cage 103.4 +/- 9.7%; oxyntomodulin/home cage 71.6712.1%, P < 0.05; oxyntomodulin/clean cage 103.0 +/- 8.5%) and attenuates the anorectic response to GLP-1 and CCK (1 h food intake reduction (% saline control): MTII/home cage 68.8 +/- 6.4%, P < 0.01; GLP-1/clean cage 80.0 +/- 9.3%; CCK/home cage 49.8 +/- 6.2%, P < 0.001; CCK/clean cage 69.4 +/- 10.6%, P < 0.05). We have also observed that exposure to a novel environment does not alter anorectic effect of peripherally administered melanocortin 3/4 receptor agonist, melanotan II ( MTII) ( 1 h food intake reduction (% saline control): MTII/home cage 32.0 +/- 6.3%, P < 0.001; MTII/clean cage 24.8 +/- 4.2%, P < 0.001). The attenuation in food intake observed following exposure to a novel environment can be attributed, in part, to a significant reduction in the food intake of the saline treated animals. In a further study, the anorectic effect of peripherally administered PYY3-36 is attenuated in unhandled rats (88 +/- 4.2% saline control, P=ns) or rats exposed to environmental enrichment (103.3 +/- 9.7% saline control, P=ns), but not in animals that were handled extensively prior to the study (80.1 +/- 7.3% saline control, P < 0.05). Conclusion: These studies highlight the importance of handling, acclimatisation and habituation of rodents to experimental conditions prior to investigating the ability of gut hormones to alter food intake.
引用
收藏
页码:288 / 292
页数:5
相关论文
共 13 条
[1]   HUMAN DISTRIBUTION AND RELEASE OF A PUTATIVE NEW GUT HORMONE, PEPTIDE-YY [J].
ADRIAN, TE ;
FERRI, GL ;
BACARESEHAMILTON, AJ ;
FUESSL, HS ;
POLAK, JM ;
BLOOM, SR .
GASTROENTEROLOGY, 1985, 89 (05) :1070-1077
[2]   Gut hormone PYY3-36 physiologically inhibits food intake [J].
Batterham, RL ;
Cowley, MA ;
Small, CJ ;
Herzog, H ;
Cohen, MA ;
Dakin, CL ;
Wren, AM ;
Brynes, AE ;
Low, MJ ;
Ghatei, MA ;
Cone, RD ;
Bloom, SR .
NATURE, 2002, 418 (6898) :650-654
[3]   Oxyntomodulin suppresses appetite and reduces food intake in humans [J].
Cohen, MA ;
Ellis, SM ;
Le Roux, CW ;
Batterham, RL ;
Park, A ;
Patterson, M ;
Frost, GS ;
Ghatei, MA ;
Bloom, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4696-4701
[4]   Peripheral oxyntomodulin reduces food intake and body weight gain in rats [J].
Dakin, CL ;
Small, CJ ;
Batterham, RL ;
Neary, NM ;
Cohen, MA ;
Patterson, M ;
Ghatei, MA ;
Bloom, SR .
ENDOCRINOLOGY, 2004, 145 (06) :2687-2695
[5]  
Duke JL, 2001, CONTEMP TOP LAB ANIM, V40, P17
[6]   Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans [J].
Flint, A ;
Raben, A ;
Astrup, A ;
Holst, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :515-520
[7]   2 MOLECULAR-FORMS OF PEPTIDE YY (PYY) ARE ABUNDANT IN HUMAN BLOOD - CHARACTERIZATION OF A RADIOIMMUNOASSAY RECOGNIZING PYY-1-36 AND PYY-3-36 [J].
GRANDT, D ;
SCHIMICZEK, M ;
BEGLINGER, C ;
LAYER, P ;
GOEBELL, H ;
EYSSELEIN, VE ;
REEVE, JR .
REGULATORY PEPTIDES, 1994, 51 (02) :151-159
[8]   Obesity research - Labs fail to reproduce protein's appetite-suppressing effects [J].
Gura, T .
SCIENCE, 2004, 305 (5681) :158-159
[9]   Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism [J].
Halatchev, IG ;
Ellacott, KLJ ;
Fan, W ;
Cone, RD .
ENDOCRINOLOGY, 2004, 145 (06) :2585-2590
[10]   Cholecystokinin and satiety: Current perspectives [J].
Moran, TH .
NUTRITION, 2000, 16 (10) :858-865